These findings establish that podocyte-specific ROCK1 activation drives key features of diabetic nephropathy, including albuminuria, structural podocyte damage, and extracellular matrix changes, independent of systemic metabolic alterations. This evidence concerns the gene ROCK1 and diabetic kidney disease.